መነሻ › ፎሊኩላር ሊምፎማ › Texas › Houston
በHouston፣ TX ለፎሊኩላር ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለፎሊኩላር ሊምፎማ የሚደረጉ 18 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Md Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Texas Children's Hospital, Houston
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Houston
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Baylor College of Medicine, Houston
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Research Site, Houston
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Center for Oncology and Blood Disorders, Houston
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MD Anderson Cancer Center, Houston
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- M D Anderson Cancer Center, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- MD Anderson Cancer Center, Houston
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The University of TX MD Anderson Cancer Center, Houston
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Oncology Consultants, Houston
- University of Texas MD Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Houston
በሌሎች ከተሞች ለፎሊኩላር ሊምፎማ የሚደረጉ ጥናቶች
- New York City, NY24 ጥናቶች
- Milwaukee, WI19 ጥናቶች
- Nashville, TN18 ጥናቶች
- Boston, MA17 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Seattle, WA15 ጥናቶች
- Durham, NC15 ጥናቶች
- Salt Lake City, UT13 ጥናቶች
- Columbus, OH13 ጥናቶች
- Chicago, IL12 ጥናቶች
- San Antonio, TX12 ጥናቶች
- Philadelphia, PA12 ጥናቶች
በHouston ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር145 ጥናቶች
- የጡንቻ ካንሰር126 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)121 ጥናቶች
- Metastatic Cancer104 ጥናቶች
- የኮሎሬክታል ካንሰር102 ጥናቶች
- የእንቁላል ካንሰር89 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ85 ጥናቶች
- የሳንባ ካንሰር78 ጥናቶች
- የፕሮስቴት ካንሰር76 ጥናቶች
- የኤንዶሜትሪየም ካንሰር68 ጥናቶች
- የፓንክሪያስ ካንሰር61 ጥናቶች
- ሜላኖማ59 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።